Albert Y. Wu, MD, PhD, FACS

Albert Wu

Assistant Professor - University Medical Line, Ophthalmology
Member, Bio-X
Member, SPARK at Stanford
Member, Maternal & Child Health Research Institute (MCHRI)
Faculty Fellow, Sarafan ChEM-H
Member, Stanford Cancer Institute
Member, Wu Tsai Neurosciences Institute
Residency: University of Utah Ophthalmology Residency (2009) UT
Board Certification: American Board of Ophthalmology, Ophthalmology (2013)
Fellowship: Toronto University Ocuplastic and Orbital Surgery Fellowship (2011) Canada
Internship: University of Utah Internal Medicine Residency (2006) UT
Medical Education: University of Washington School of Medicine (2005) WA
PhD, University of Washington, Molecular and Cellular Biology
BS, Yale University, Molecular Biophysics and Biochemistry
Dr. Wu is a board-certified ophthalmologist and a fellowship-trained specialist in oculoplastic and orbital surgery. This specialty is dedicated to care of the eyelid and other structures around the eye. It is also called ophthalmic plastic and reconstructive surgery.

Dr. Wu focuses his expertise on saving people’s vision. He provides comprehensive, compassionate care for both adults and children with sight-threatening diseases and injuries of the eye and surrounding area. He treats tearing, eyelid drooping, thyroid eye disease, eyelid tumors, and other facial disorders. He also performs facial rejuvenation as well as reconstructive and aesthetic surgery procedures.

Dr. Wu is a national leader in advancing the use of stem cell therapy to treat conditions involving the eye and face. His research explores how stem cells can regenerate a patient’s own tissues for potential transplant. His goal is to make regenerative medicine an accepted treatment for people worldwide suffering from diseases of the eye.

The National Eye Institute funded Dr. Wu’s research to develop stem cell therapies to treat corneal blindness and regenerate the surface of the eye. He leads the Stanford Ophthalmic Stem Cell and Regenerative Medicine Laboratory and is developing leading-edge treatments for vision loss and eye disease.

He also has participated as a principal investigator in research projects including “The Human Eye Cell Atlas.” The goal of this project is to create a reference atlas of all cell types in the human eye. Dr. Wu is also helping to lead a groundbreaking study of a strategy for reconstruction of the surface of the eye. These projects are among more than a dozen involving Dr. Wu that have explored innovations in medication and surgical technique for eye disorders.

He has co-authored articles on his research discoveries in JAMA Ophthalmology, Ophthalmic Plastic & Reconstructive Surgery, Clinical and Experimental Ophthalmology, Retina, Medical Research and Innovations, and many other peer-reviewed publications. He is an article reviewer for publications including the American Journal of Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery, and Human Gene Therapy.

He also has contributed to chapters in the textbooks Ophthalmology and Ophthalmologic Oncology: Mount Sinai Expert Guides.

Dr. Wu has presented the findings of his research at numerous international, national, and local conferences. They include meetings of the North American Society of Academic Oculoplastic Surgeons, Endocrine Society, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), and others. Topics have included the stem cells and other approaches to perform regeneration procedures on the eye.

Dr. Wu has earned honors for his clinical, research, and academic achievements. He has won awards from the National Institutes of Health, American Society of Ophthalmic Plastic and Reconstructive Surgery, Icahn School of Medicine at Mount Sinai, the University of Washington, and Yale University.